Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
Co-development partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the market. Event if the licensor does not commercialize the project they can either sell those rights to the licensee partner or another partner for an amount higher than would have been achieved at an earlier stage licensing deal.
The global market for Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics players cover 1ST Biotherapeutics, 3B Pharmaceuticals, 3D-Micromac, 3DMed and 3D Systems, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market, with both quantitative and qualitative data, to help readers understand how the Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market and forecasts the market size by Type (Asset purchase, Assignment and Co-development), by Application (Industry sector, Therapy areas, Technology type and Deal components), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, Research Methodology, etc.
Chapter 2: Executive Summary, global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market size and CAGR, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including 1ST Biotherapeutics, 3B Pharmaceuticals, 3D-Micromac, 3DMed, 3D Systems, 10X Genomics, A*STAR Agency for Science, Technology and Research and A*STAR Institute of Microelectronics (IME), etc.
Chapter 14: Research Findings and Conclusion
Co-development partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the market. Event if the licensor does not commercialize the project they can either sell those rights to the licensee partner or another partner for an amount higher than would have been achieved at an earlier stage licensing deal.
The global market for Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics players cover 1ST Biotherapeutics, 3B Pharmaceuticals, 3D-Micromac, 3DMed and 3D Systems, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market, with both quantitative and qualitative data, to help readers understand how the Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market and forecasts the market size by Type (Asset purchase, Assignment and Co-development), by Application (Industry sector, Therapy areas, Technology type and Deal components), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Others
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- 1ST Biotherapeutics
- 3B Pharmaceuticals
- 3D-Micromac
- 3DMed
- 3D Systems
- 10X Genomics
- A*STAR Agency for Science
- Technology and Research
- A*STAR Institute of Microelectronics (IME)
- A2A Pharmaceuticals
- Abbvie
- AbCellera
- ABL Bio
- Abpro
- Academy of Military Medical Sciences (China)
- Accellix
- Accord Healthcare
- AccuGenomics
- ACEA Biosciences
- AC Immune
- Acoustic MedSystems
- Adaptimmune
- Aduro BioTech
- Advaxis
- Adventus Ventures
- Aerolase
Chapter 1: Scope of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, Research Methodology, etc.
Chapter 2: Executive Summary, global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market size and CAGR, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including 1ST Biotherapeutics, 3B Pharmaceuticals, 3D-Micromac, 3DMed, 3D Systems, 10X Genomics, A*STAR Agency for Science, Technology and Research and A*STAR Institute of Microelectronics (IME), etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2017-2028
2.1.2 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Segment by Type
2.2.1 Asset purchase
2.2.2 Assignment
2.2.3 Co-development
2.2.4 Co-market
2.2.5 Co-promotion
2.2.6 Collaborative R&D
2.2.7 Contract service
2.2.8 CRADA
2.2.9 Cross-licensing
2.2.10 Others
2.3 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type
2.3.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type (2017-2022)
2.4 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Segment by Application
2.4.1 Industry sector
2.4.2 Therapy areas
2.4.3 Technology type
2.4.4 Deal components
2.4.5 Financial terms
2.4.6 Stage of development
2.4.7 Others
2.5 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application
2.5.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application (2017-2022)
3 CO-DEVELOPMENT PARTNERING TERMS AND AGREEMENTS IN PHARMA, BIOTECH AND DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Players
3.1.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Players (2020-2022)
3.1.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CO-DEVELOPMENT PARTNERING TERMS AND AGREEMENTS IN PHARMA, BIOTECH AND DIAGNOSTICS BY REGIONS
4.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Regions (2017-2022)
4.2 Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth (2017-2022)
4.3 APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth (2017-2022)
4.4 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2017-2022)
5.2 Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022)
5.3 Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2017-2022)
6.2 APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022)
6.3 APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics by Country (2017-2022)
7.2 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022)
7.3 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics by Region (2017-2022)
8.2 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CO-DEVELOPMENT PARTNERING TERMS AND AGREEMENTS IN PHARMA, BIOTECH AND DIAGNOSTICS MARKET FORECAST
10.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast
10.1.3 APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast
10.1.4 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast
10.1.5 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast
10.2 Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Country (2023-2028)
10.2.1 United States Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.2.2 Canada Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.2.3 Mexico Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.2.4 Brazil Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.3 APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Region (2023-2028)
10.3.1 China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.3.2 Japan Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.3.3 Korea Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.3.4 Southeast Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.3.5 India Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.3.6 Australia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.4 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.4.2 France Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.4.3 UK Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.4.4 Italy Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.4.5 Russia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.5 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.5.2 South Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.5.3 Israel Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.5.4 Turkey Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.5.5 GCC Countries Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.6 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Type (2023-2028)
10.7 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 1ST Biotherapeutics
11.1.1 1ST Biotherapeutics Company Information
11.1.2 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.1.3 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 1ST Biotherapeutics Main Business Overview
11.1.5 1ST Biotherapeutics Latest Developments
11.2 3B Pharmaceuticals
11.2.1 3B Pharmaceuticals Company Information
11.2.2 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.2.3 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 3B Pharmaceuticals Main Business Overview
11.2.5 3B Pharmaceuticals Latest Developments
11.3 3D-Micromac
11.3.1 3D-Micromac Company Information
11.3.2 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.3.3 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 3D-Micromac Main Business Overview
11.3.5 3D-Micromac Latest Developments
11.4 3DMed
11.4.1 3DMed Company Information
11.4.2 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.4.3 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 3DMed Main Business Overview
11.4.5 3DMed Latest Developments
11.5 3D Systems
11.5.1 3D Systems Company Information
11.5.2 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.5.3 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 3D Systems Main Business Overview
11.5.5 3D Systems Latest Developments
11.6 10X Genomics
11.6.1 10X Genomics Company Information
11.6.2 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.6.3 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 10X Genomics Main Business Overview
11.6.5 10X Genomics Latest Developments
11.7 A*STAR Agency for Science
11.7.1 A*STAR Agency for Science Company Information
11.7.2 A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.7.3 A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 A*STAR Agency for Science Main Business Overview
11.7.5 A*STAR Agency for Science Latest Developments
11.8 Technology and Research
11.8.1 Technology and Research Company Information
11.8.2 Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.8.3 Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Technology and Research Main Business Overview
11.8.5 Technology and Research Latest Developments
11.9 A*STAR Institute of Microelectronics (IME)
11.9.1 A*STAR Institute of Microelectronics (IME) Company Information
11.9.2 A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.9.3 A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 A*STAR Institute of Microelectronics (IME) Main Business Overview
11.9.5 A*STAR Institute of Microelectronics (IME) Latest Developments
11.10 A2A Pharmaceuticals
11.10.1 A2A Pharmaceuticals Company Information
11.10.2 A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.10.3 A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 A2A Pharmaceuticals Main Business Overview
11.10.5 A2A Pharmaceuticals Latest Developments
11.11 Abbvie
11.11.1 Abbvie Company Information
11.11.2 Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.11.3 Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Abbvie Main Business Overview
11.11.5 Abbvie Latest Developments
11.12 AbCellera
11.12.1 AbCellera Company Information
11.12.2 AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.12.3 AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 AbCellera Main Business Overview
11.12.5 AbCellera Latest Developments
11.13 ABL Bio
11.13.1 ABL Bio Company Information
11.13.2 ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.13.3 ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 ABL Bio Main Business Overview
11.13.5 ABL Bio Latest Developments
11.14 Abpro
11.14.1 Abpro Company Information
11.14.2 Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.14.3 Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Abpro Main Business Overview
11.14.5 Abpro Latest Developments
11.15 Academy of Military Medical Sciences (China)
11.15.1 Academy of Military Medical Sciences (China) Company Information
11.15.2 Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.15.3 Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Academy of Military Medical Sciences (China) Main Business Overview
11.15.5 Academy of Military Medical Sciences (China) Latest Developments
11.16 Accellix
11.16.1 Accellix Company Information
11.16.2 Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.16.3 Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Accellix Main Business Overview
11.16.5 Accellix Latest Developments
11.17 Accord Healthcare
11.17.1 Accord Healthcare Company Information
11.17.2 Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.17.3 Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Accord Healthcare Main Business Overview
11.17.5 Accord Healthcare Latest Developments
11.18 AccuGenomics
11.18.1 AccuGenomics Company Information
11.18.2 AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.18.3 AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 AccuGenomics Main Business Overview
11.18.5 AccuGenomics Latest Developments
11.19 ACEA Biosciences
11.19.1 ACEA Biosciences Company Information
11.19.2 ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.19.3 ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 ACEA Biosciences Main Business Overview
11.19.5 ACEA Biosciences Latest Developments
11.20 AC Immune
11.20.1 AC Immune Company Information
11.20.2 AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.20.3 AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 AC Immune Main Business Overview
11.20.5 AC Immune Latest Developments
11.21 Acoustic MedSystems
11.21.1 Acoustic MedSystems Company Information
11.21.2 Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.21.3 Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Acoustic MedSystems Main Business Overview
11.21.5 Acoustic MedSystems Latest Developments
11.22 Adaptimmune
11.22.1 Adaptimmune Company Information
11.22.2 Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.22.3 Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Adaptimmune Main Business Overview
11.22.5 Adaptimmune Latest Developments
11.23 Aduro BioTech
11.23.1 Aduro BioTech Company Information
11.23.2 Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.23.3 Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Aduro BioTech Main Business Overview
11.23.5 Aduro BioTech Latest Developments
11.24 Advaxis
11.24.1 Advaxis Company Information
11.24.2 Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.24.3 Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 Advaxis Main Business Overview
11.24.5 Advaxis Latest Developments
11.25 Adventus Ventures
11.25.1 Adventus Ventures Company Information
11.25.2 Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.25.3 Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 Adventus Ventures Main Business Overview
11.25.5 Adventus Ventures Latest Developments
11.26 Aerolase
11.26.1 Aerolase Company Information
11.26.2 Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.26.3 Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Aerolase Main Business Overview
11.26.5 Aerolase Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2017-2028
2.1.2 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Segment by Type
2.2.1 Asset purchase
2.2.2 Assignment
2.2.3 Co-development
2.2.4 Co-market
2.2.5 Co-promotion
2.2.6 Collaborative R&D
2.2.7 Contract service
2.2.8 CRADA
2.2.9 Cross-licensing
2.2.10 Others
2.3 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type
2.3.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type (2017-2022)
2.4 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Segment by Application
2.4.1 Industry sector
2.4.2 Therapy areas
2.4.3 Technology type
2.4.4 Deal components
2.4.5 Financial terms
2.4.6 Stage of development
2.4.7 Others
2.5 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application
2.5.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application (2017-2022)
3 CO-DEVELOPMENT PARTNERING TERMS AND AGREEMENTS IN PHARMA, BIOTECH AND DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Players
3.1.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Players (2020-2022)
3.1.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CO-DEVELOPMENT PARTNERING TERMS AND AGREEMENTS IN PHARMA, BIOTECH AND DIAGNOSTICS BY REGIONS
4.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Regions (2017-2022)
4.2 Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth (2017-2022)
4.3 APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth (2017-2022)
4.4 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2017-2022)
5.2 Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022)
5.3 Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2017-2022)
6.2 APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022)
6.3 APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics by Country (2017-2022)
7.2 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022)
7.3 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics by Region (2017-2022)
8.2 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CO-DEVELOPMENT PARTNERING TERMS AND AGREEMENTS IN PHARMA, BIOTECH AND DIAGNOSTICS MARKET FORECAST
10.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast
10.1.3 APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast
10.1.4 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast
10.1.5 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast
10.2 Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Country (2023-2028)
10.2.1 United States Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.2.2 Canada Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.2.3 Mexico Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.2.4 Brazil Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.3 APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Region (2023-2028)
10.3.1 China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.3.2 Japan Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.3.3 Korea Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.3.4 Southeast Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.3.5 India Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.3.6 Australia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.4 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.4.2 France Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.4.3 UK Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.4.4 Italy Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.4.5 Russia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.5 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.5.2 South Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.5.3 Israel Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.5.4 Turkey Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.5.5 GCC Countries Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Forecast
10.6 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Type (2023-2028)
10.7 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 1ST Biotherapeutics
11.1.1 1ST Biotherapeutics Company Information
11.1.2 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.1.3 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 1ST Biotherapeutics Main Business Overview
11.1.5 1ST Biotherapeutics Latest Developments
11.2 3B Pharmaceuticals
11.2.1 3B Pharmaceuticals Company Information
11.2.2 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.2.3 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 3B Pharmaceuticals Main Business Overview
11.2.5 3B Pharmaceuticals Latest Developments
11.3 3D-Micromac
11.3.1 3D-Micromac Company Information
11.3.2 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.3.3 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 3D-Micromac Main Business Overview
11.3.5 3D-Micromac Latest Developments
11.4 3DMed
11.4.1 3DMed Company Information
11.4.2 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.4.3 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 3DMed Main Business Overview
11.4.5 3DMed Latest Developments
11.5 3D Systems
11.5.1 3D Systems Company Information
11.5.2 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.5.3 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 3D Systems Main Business Overview
11.5.5 3D Systems Latest Developments
11.6 10X Genomics
11.6.1 10X Genomics Company Information
11.6.2 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.6.3 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 10X Genomics Main Business Overview
11.6.5 10X Genomics Latest Developments
11.7 A*STAR Agency for Science
11.7.1 A*STAR Agency for Science Company Information
11.7.2 A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.7.3 A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 A*STAR Agency for Science Main Business Overview
11.7.5 A*STAR Agency for Science Latest Developments
11.8 Technology and Research
11.8.1 Technology and Research Company Information
11.8.2 Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.8.3 Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Technology and Research Main Business Overview
11.8.5 Technology and Research Latest Developments
11.9 A*STAR Institute of Microelectronics (IME)
11.9.1 A*STAR Institute of Microelectronics (IME) Company Information
11.9.2 A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.9.3 A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 A*STAR Institute of Microelectronics (IME) Main Business Overview
11.9.5 A*STAR Institute of Microelectronics (IME) Latest Developments
11.10 A2A Pharmaceuticals
11.10.1 A2A Pharmaceuticals Company Information
11.10.2 A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.10.3 A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 A2A Pharmaceuticals Main Business Overview
11.10.5 A2A Pharmaceuticals Latest Developments
11.11 Abbvie
11.11.1 Abbvie Company Information
11.11.2 Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.11.3 Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Abbvie Main Business Overview
11.11.5 Abbvie Latest Developments
11.12 AbCellera
11.12.1 AbCellera Company Information
11.12.2 AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.12.3 AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 AbCellera Main Business Overview
11.12.5 AbCellera Latest Developments
11.13 ABL Bio
11.13.1 ABL Bio Company Information
11.13.2 ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.13.3 ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 ABL Bio Main Business Overview
11.13.5 ABL Bio Latest Developments
11.14 Abpro
11.14.1 Abpro Company Information
11.14.2 Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.14.3 Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Abpro Main Business Overview
11.14.5 Abpro Latest Developments
11.15 Academy of Military Medical Sciences (China)
11.15.1 Academy of Military Medical Sciences (China) Company Information
11.15.2 Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.15.3 Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Academy of Military Medical Sciences (China) Main Business Overview
11.15.5 Academy of Military Medical Sciences (China) Latest Developments
11.16 Accellix
11.16.1 Accellix Company Information
11.16.2 Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.16.3 Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Accellix Main Business Overview
11.16.5 Accellix Latest Developments
11.17 Accord Healthcare
11.17.1 Accord Healthcare Company Information
11.17.2 Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.17.3 Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Accord Healthcare Main Business Overview
11.17.5 Accord Healthcare Latest Developments
11.18 AccuGenomics
11.18.1 AccuGenomics Company Information
11.18.2 AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.18.3 AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 AccuGenomics Main Business Overview
11.18.5 AccuGenomics Latest Developments
11.19 ACEA Biosciences
11.19.1 ACEA Biosciences Company Information
11.19.2 ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.19.3 ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 ACEA Biosciences Main Business Overview
11.19.5 ACEA Biosciences Latest Developments
11.20 AC Immune
11.20.1 AC Immune Company Information
11.20.2 AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.20.3 AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 AC Immune Main Business Overview
11.20.5 AC Immune Latest Developments
11.21 Acoustic MedSystems
11.21.1 Acoustic MedSystems Company Information
11.21.2 Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.21.3 Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Acoustic MedSystems Main Business Overview
11.21.5 Acoustic MedSystems Latest Developments
11.22 Adaptimmune
11.22.1 Adaptimmune Company Information
11.22.2 Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.22.3 Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Adaptimmune Main Business Overview
11.22.5 Adaptimmune Latest Developments
11.23 Aduro BioTech
11.23.1 Aduro BioTech Company Information
11.23.2 Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.23.3 Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Aduro BioTech Main Business Overview
11.23.5 Aduro BioTech Latest Developments
11.24 Advaxis
11.24.1 Advaxis Company Information
11.24.2 Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.24.3 Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 Advaxis Main Business Overview
11.24.5 Advaxis Latest Developments
11.25 Adventus Ventures
11.25.1 Adventus Ventures Company Information
11.25.2 Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.25.3 Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 Adventus Ventures Main Business Overview
11.25.5 Adventus Ventures Latest Developments
11.26 Aerolase
11.26.1 Aerolase Company Information
11.26.2 Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
11.26.3 Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Aerolase Main Business Overview
11.26.5 Aerolase Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Asset purchase
Table 3. Major Players of Assignment
Table 4. Major Players of Co-development
Table 5. Major Players of Co-market
Table 6. Major Players of Co-promotion
Table 7. Major Players of Collaborative R&D
Table 8. Major Players of Contract service
Table 9. Major Players of CRADA
Table 10. Major Players of Cross-licensing
Table 11. Major Players of Others
Table 12. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 14. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type (2017-2022)
Table 15. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 16. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 17. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application (2017-2022)
Table 18. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Players (2020-2022) & ($ Millions)
Table 19. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Player (2020-2022)
Table 20. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Key Players Head office and Products Offered
Table 21. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
Table 25. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Regions (2017-2022)
Table 26. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 27. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Country (2017-2022)
Table 28. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 29. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type (2017-2022)
Table 30. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 31. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application (2017-2022)
Table 32. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 33. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Region (2017-2022)
Table 34. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 35. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type (2017-2022)
Table 36. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 37. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application (2017-2022)
Table 38. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 39. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Country (2017-2022)
Table 40. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 41. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type (2017-2022)
Table 42. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 43. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application (2017-2022)
Table 44. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Region (2017-2022)
Table 46. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 47. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type (2017-2022)
Table 48. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 49. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application (2017-2022)
Table 50. Key Market Drivers & Growth Opportunities of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Table 51. Key Market Challenges & Risks of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Table 52. Key Industry Trends of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Table 53. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 54. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
Table 55. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 56. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share Forecast by Type (2023-2028)
Table 57. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 58. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share Forecast by Application (2023-2028)
Table 59. 1ST Biotherapeutics Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 60. 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 61. 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. 1ST Biotherapeutics Main Business
Table 63. 1ST Biotherapeutics Latest Developments
Table 64. 3B Pharmaceuticals Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 65. 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 66. 3B Pharmaceuticals Main Business
Table 67. 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. 3B Pharmaceuticals Latest Developments
Table 69. 3D-Micromac Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 70. 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 71. 3D-Micromac Main Business
Table 72. 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. 3D-Micromac Latest Developments
Table 74. 3DMed Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 75. 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 76. 3DMed Main Business
Table 77. 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. 3DMed Latest Developments
Table 79. 3D Systems Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 80. 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 81. 3D Systems Main Business
Table 82. 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. 3D Systems Latest Developments
Table 84. 10X Genomics Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 85. 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 86. 10X Genomics Main Business
Table 87. 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. 10X Genomics Latest Developments
Table 89. A*STAR Agency for Science Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 90. A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 91. A*STAR Agency for Science Main Business
Table 92. A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. A*STAR Agency for Science Latest Developments
Table 94. Technology and Research Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 95. Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 96. Technology and Research Main Business
Table 97. Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Technology and Research Latest Developments
Table 99. A*STAR Institute of Microelectronics (IME) Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 100. A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 101. A*STAR Institute of Microelectronics (IME) Main Business
Table 102. A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. A*STAR Institute of Microelectronics (IME) Latest Developments
Table 104. A2A Pharmaceuticals Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 105. A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 106. A2A Pharmaceuticals Main Business
Table 107. A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 108. A2A Pharmaceuticals Latest Developments
Table 109. Abbvie Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 110. Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 111. Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Abbvie Main Business
Table 113. Abbvie Latest Developments
Table 114. AbCellera Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 115. AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 116. AbCellera Main Business
Table 117. AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. AbCellera Latest Developments
Table 119. ABL Bio Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 120. ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 121. ABL Bio Main Business
Table 122. ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. ABL Bio Latest Developments
Table 124. Abpro Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 125. Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 126. Abpro Main Business
Table 127. Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Abpro Latest Developments
Table 129. Academy of Military Medical Sciences (China) Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 130. Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 131. Academy of Military Medical Sciences (China) Main Business
Table 132. Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. Academy of Military Medical Sciences (China) Latest Developments
Table 134. Accellix Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 135. Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 136. Accellix Main Business
Table 137. Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Accellix Latest Developments
Table 139. Accord Healthcare Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 140. Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 141. Accord Healthcare Main Business
Table 142. Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. Accord Healthcare Latest Developments
Table 144. AccuGenomics Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 145. AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 146. AccuGenomics Main Business
Table 147. AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 148. AccuGenomics Latest Developments
Table 149. ACEA Biosciences Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 150. ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 151. ACEA Biosciences Main Business
Table 152. ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 153. ACEA Biosciences Latest Developments
Table 154. AC Immune Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 155. AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 156. AC Immune Main Business
Table 157. AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 158. AC Immune Latest Developments
Table 159. Acoustic MedSystems Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 160. Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 161. Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 162. Acoustic MedSystems Main Business
Table 163. Acoustic MedSystems Latest Developments
Table 164. Adaptimmune Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 165. Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 166. Adaptimmune Main Business
Table 167. Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 168. Adaptimmune Latest Developments
Table 169. Aduro BioTech Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 170. Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 171. Aduro BioTech Main Business
Table 172. Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 173. Aduro BioTech Latest Developments
Table 174. Advaxis Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 175. Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 176. Advaxis Main Business
Table 177. Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 178. Advaxis Latest Developments
Table 179. Adventus Ventures Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 180. Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 181. Adventus Ventures Main Business
Table 182. Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 183. Adventus Ventures Latest Developments
Table 184. Aerolase Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 185. Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 186. Aerolase Main Business
Table 187. Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 188. Aerolase Latest Developments
Table 1. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Asset purchase
Table 3. Major Players of Assignment
Table 4. Major Players of Co-development
Table 5. Major Players of Co-market
Table 6. Major Players of Co-promotion
Table 7. Major Players of Collaborative R&D
Table 8. Major Players of Contract service
Table 9. Major Players of CRADA
Table 10. Major Players of Cross-licensing
Table 11. Major Players of Others
Table 12. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 14. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type (2017-2022)
Table 15. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 16. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 17. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application (2017-2022)
Table 18. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Players (2020-2022) & ($ Millions)
Table 19. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Player (2020-2022)
Table 20. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Key Players Head office and Products Offered
Table 21. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
Table 25. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Regions (2017-2022)
Table 26. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 27. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Country (2017-2022)
Table 28. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 29. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type (2017-2022)
Table 30. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 31. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application (2017-2022)
Table 32. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 33. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Region (2017-2022)
Table 34. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 35. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type (2017-2022)
Table 36. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 37. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application (2017-2022)
Table 38. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 39. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Country (2017-2022)
Table 40. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 41. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type (2017-2022)
Table 42. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 43. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application (2017-2022)
Table 44. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Region (2017-2022)
Table 46. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 47. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type (2017-2022)
Table 48. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 49. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application (2017-2022)
Table 50. Key Market Drivers & Growth Opportunities of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Table 51. Key Market Challenges & Risks of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Table 52. Key Industry Trends of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Table 53. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 54. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
Table 55. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 56. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share Forecast by Type (2023-2028)
Table 57. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 58. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share Forecast by Application (2023-2028)
Table 59. 1ST Biotherapeutics Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 60. 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 61. 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. 1ST Biotherapeutics Main Business
Table 63. 1ST Biotherapeutics Latest Developments
Table 64. 3B Pharmaceuticals Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 65. 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 66. 3B Pharmaceuticals Main Business
Table 67. 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. 3B Pharmaceuticals Latest Developments
Table 69. 3D-Micromac Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 70. 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 71. 3D-Micromac Main Business
Table 72. 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. 3D-Micromac Latest Developments
Table 74. 3DMed Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 75. 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 76. 3DMed Main Business
Table 77. 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. 3DMed Latest Developments
Table 79. 3D Systems Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 80. 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 81. 3D Systems Main Business
Table 82. 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. 3D Systems Latest Developments
Table 84. 10X Genomics Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 85. 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 86. 10X Genomics Main Business
Table 87. 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. 10X Genomics Latest Developments
Table 89. A*STAR Agency for Science Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 90. A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 91. A*STAR Agency for Science Main Business
Table 92. A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. A*STAR Agency for Science Latest Developments
Table 94. Technology and Research Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 95. Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 96. Technology and Research Main Business
Table 97. Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Technology and Research Latest Developments
Table 99. A*STAR Institute of Microelectronics (IME) Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 100. A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 101. A*STAR Institute of Microelectronics (IME) Main Business
Table 102. A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. A*STAR Institute of Microelectronics (IME) Latest Developments
Table 104. A2A Pharmaceuticals Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 105. A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 106. A2A Pharmaceuticals Main Business
Table 107. A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 108. A2A Pharmaceuticals Latest Developments
Table 109. Abbvie Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 110. Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 111. Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Abbvie Main Business
Table 113. Abbvie Latest Developments
Table 114. AbCellera Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 115. AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 116. AbCellera Main Business
Table 117. AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. AbCellera Latest Developments
Table 119. ABL Bio Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 120. ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 121. ABL Bio Main Business
Table 122. ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. ABL Bio Latest Developments
Table 124. Abpro Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 125. Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 126. Abpro Main Business
Table 127. Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Abpro Latest Developments
Table 129. Academy of Military Medical Sciences (China) Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 130. Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 131. Academy of Military Medical Sciences (China) Main Business
Table 132. Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. Academy of Military Medical Sciences (China) Latest Developments
Table 134. Accellix Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 135. Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 136. Accellix Main Business
Table 137. Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Accellix Latest Developments
Table 139. Accord Healthcare Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 140. Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 141. Accord Healthcare Main Business
Table 142. Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. Accord Healthcare Latest Developments
Table 144. AccuGenomics Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 145. AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 146. AccuGenomics Main Business
Table 147. AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 148. AccuGenomics Latest Developments
Table 149. ACEA Biosciences Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 150. ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 151. ACEA Biosciences Main Business
Table 152. ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 153. ACEA Biosciences Latest Developments
Table 154. AC Immune Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 155. AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 156. AC Immune Main Business
Table 157. AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 158. AC Immune Latest Developments
Table 159. Acoustic MedSystems Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 160. Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 161. Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 162. Acoustic MedSystems Main Business
Table 163. Acoustic MedSystems Latest Developments
Table 164. Adaptimmune Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 165. Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 166. Adaptimmune Main Business
Table 167. Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 168. Adaptimmune Latest Developments
Table 169. Aduro BioTech Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 170. Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 171. Aduro BioTech Main Business
Table 172. Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 173. Aduro BioTech Latest Developments
Table 174. Advaxis Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 175. Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 176. Advaxis Main Business
Table 177. Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 178. Advaxis Latest Developments
Table 179. Adventus Ventures Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 180. Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 181. Adventus Ventures Main Business
Table 182. Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 183. Adventus Ventures Latest Developments
Table 184. Aerolase Details, Company Type, Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Area Served and Its Competitors
Table 185. Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Offered
Table 186. Aerolase Main Business
Table 187. Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 188. Aerolase Latest Developments
LIST OF FIGURES
LIST OF FIGURES
Figure 1. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type in 2021
Figure 7. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics in Industry sector
Figure 8. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market: Industry sector (2017-2022) & ($ Millions)
Figure 9. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics in Therapy areas
Figure 10. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market: Therapy areas (2017-2022) & ($ Millions)
Figure 11. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics in Technology type
Figure 12. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market: Technology type (2017-2022) & ($ Millions)
Figure 13. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics in Deal components
Figure 14. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market: Deal components (2017-2022) & ($ Millions)
Figure 15. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics in Financial terms
Figure 16. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market: Financial terms (2017-2022) & ($ Millions)
Figure 17. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics in Stage of development
Figure 18. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market: Stage of development (2017-2022) & ($ Millions)
Figure 19. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics in Others
Figure 20. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market: Others (2017-2022) & ($ Millions)
Figure 21. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application in 2021
Figure 22. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Player in 2021
Figure 23. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Regions (2017-2022)
Figure 24. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2017-2022 ($ Millions)
Figure 25. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2017-2022 ($ Millions)
Figure 26. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2017-2022 ($ Millions)
Figure 27. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2017-2022 ($ Millions)
Figure 28. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Value Market Share by Country in 2021
Figure 29. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Consumption Market Share by Type in 2021
Figure 30. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application in 2021
Figure 31. United States Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Canada Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Mexico Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Brazil Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 35. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Region in 2021
Figure 36. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application in 2021
Figure 37. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 38. Japan Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Korea Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 40. Southeast Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 41. India Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Australia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Country in 2021
Figure 44. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type in 2021
Figure 45. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application in 2021
Figure 46. Germany Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 47. France Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 48. UK Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Italy Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 50. Russia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Region in 2021
Figure 52. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type in 2021
Figure 53. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application in 2021
Figure 54. Egypt Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 55. South Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 56. Israel Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 57. Turkey Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 58. GCC Country Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 59. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 60. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 61. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 62. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 20
LIST OF FIGURES
Figure 1. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type in 2021
Figure 7. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics in Industry sector
Figure 8. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market: Industry sector (2017-2022) & ($ Millions)
Figure 9. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics in Therapy areas
Figure 10. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market: Therapy areas (2017-2022) & ($ Millions)
Figure 11. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics in Technology type
Figure 12. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market: Technology type (2017-2022) & ($ Millions)
Figure 13. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics in Deal components
Figure 14. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market: Deal components (2017-2022) & ($ Millions)
Figure 15. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics in Financial terms
Figure 16. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market: Financial terms (2017-2022) & ($ Millions)
Figure 17. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics in Stage of development
Figure 18. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market: Stage of development (2017-2022) & ($ Millions)
Figure 19. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics in Others
Figure 20. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market: Others (2017-2022) & ($ Millions)
Figure 21. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application in 2021
Figure 22. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Player in 2021
Figure 23. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Regions (2017-2022)
Figure 24. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2017-2022 ($ Millions)
Figure 25. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2017-2022 ($ Millions)
Figure 26. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2017-2022 ($ Millions)
Figure 27. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2017-2022 ($ Millions)
Figure 28. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Value Market Share by Country in 2021
Figure 29. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Consumption Market Share by Type in 2021
Figure 30. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application in 2021
Figure 31. United States Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Canada Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Mexico Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Brazil Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 35. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Region in 2021
Figure 36. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application in 2021
Figure 37. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 38. Japan Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Korea Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 40. Southeast Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 41. India Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Australia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Country in 2021
Figure 44. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type in 2021
Figure 45. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application in 2021
Figure 46. Germany Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 47. France Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 48. UK Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Italy Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 50. Russia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Region in 2021
Figure 52. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Type in 2021
Figure 53. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Market Share by Application in 2021
Figure 54. Egypt Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 55. South Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 56. Israel Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 57. Turkey Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 58. GCC Country Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 59. Americas Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 60. APAC Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 61. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 62. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size 20
